Jie Wen Gao
Director of Finance/CFO at MingMed Biotechnology Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hui Ou Yang | M | 52 |
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 5 years |
| Yan Zhang | M | 52 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 5 years |
| Miao Liu | M | 53 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 5 years |
| Wing Ho Ngan | M | 50 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | - |
| Ming Guo Huang | M | 52 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 5 years |
| Chong Sun Chung | M | 48 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | - |
| Wei Wen Hou | M | 49 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | - |
| Sau Shan Ku | M | 55 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 2 years |
| Dong Zhang | M | 48 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 2 years |
| Jiang Tao Yu | M | 49 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 3 years |
| Maio Li Pan | F | 47 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 2 years |
| Wei Wang | M | 52 |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Showbhik Kalra | M | - |
Nanyang Technological University
| 4 years |
| Qing Yang Gu | M | 63 |
Nanyang Technological University
| 9 years |
| Boon Chua | M | - |
Nanyang Technological University
| 2 years |
| Hou-Sen Lim | M | 50 |
Nanyang Technological University
| 6 years |
| Xue Bin Liu | M | - |
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | 3 years |
| Yiow Min Chay | M | 50 |
Nanyang Technological University
| 7 years |
| Ching Yau Yi | F | - |
Nanyang Technological University
| 4 years |
| Xiao Yang Guo | M | 56 |
Nanyang Technological University
| 4 years |
| Kheng Koh Wee | M | 43 |
Nanyang Technological University
| 4 years |
| Terence Henry Jennings | M | 78 |
Nanyang Technological University
| 3 years |
| Jason Tan | M | - |
Nanyang Technological University
| 4 years |
| Jian Fong Tan | M | 48 |
Nanyang Technological University
| 4 years |
| Soocelaraj Ganessaraj | M | 50 |
Nanyang Technological University
| 4 years |
| Yee-Loy Lam | M | - |
Nanyang Technological University
| 10 years |
| Yee Kiat Koh | M | 49 |
Nanyang Technological University
| 4 years |
| Xu Shi | M | 61 |
Nanyang Technological University
| 3 years |
| Wai Man Cheung | M | 46 |
Nanyang Technological University
| 3 years |
| Teng Hooi Tan | M | 66 |
Nanyang Technological University
| 3 years |
| Teck Whee Poh | M | 49 |
Nanyang Technological University
| 4 years |
| Wei Wei Lim | M | 47 |
Nanyang Technological University
| 4 years |
| Chun Wai Ng | M | 46 |
Nanyang Technological University
| 4 years |
| Li Ying Koh | F | 41 |
Nanyang Technological University
| 4 years |
| Swee Ann Phua | M | 43 |
Nanyang Technological University
| 4 years |
| Ronald Adrianta | M | 41 |
Nanyang Technological University
| 4 years |
| Piyush Sharma | M | 57 |
Nanyang Technological University
| 4 years |
| Beng Tat Yap | M | 42 |
Nanyang Technological University
| 4 years |
| Catherine Hindra Sutjahyo | F | 41 |
Nanyang Technological University
| 4 years |
| Joanne Baudin | F | - |
Nanyang Technological University
| 3 years |
| Soon Tong Lim | M | 60 |
Nanyang Technological University
| 2 years |
| Tze Ren Poh | M | - |
Nanyang Technological University
| 4 years |
| Victor Putra Lesmana | M | 42 |
Nanyang Technological University
| 4 years |
| Kheng Hong Chiang | M | 56 |
Nanyang Technological University
| 2 years |
| Iwan Tjam | M | - |
Nanyang Technological University
| 4 years |
| Shuwen Koh | F | - |
Nanyang Technological University
| 3 years |
| Indriani Suhartono | F | 43 |
Nanyang Technological University
| 4 years |
| Jun Yang | M | 43 |
Nanyang Technological University
| 4 years |
| David Tran | M | - |
Nanyang Technological University
| 3 years |
| Ferdinand Rivany | M | - |
Nanyang Technological University
| 4 years |
| Bee Yee Ng | F | 48 |
Nanyang Technological University
| 4 years |
| Keith Loo | M | - |
Nanyang Technological University
| - |
| Emma Cui | F | - |
Nanyang Technological University
| 4 years |
| Noi Keng Koh | M | 63 |
Nanyang Technological University
| - |
| Teck Yong Heng | M | 51 |
Nanyang Technological University
| 4 years |
| Yip Sin Chi | M | 48 |
Nanyang Technological University
| 4 years |
| Genping Liu | M | - |
Nanyang Technological University
| 6 years |
| Han Boon Toh | M | 41 |
Nanyang Technological University
| 4 years |
| Chee Chong Lim | M | 45 |
Nanyang Technological University
| 3 years |
| Han Beng Tan | M | 49 |
Nanyang Technological University
| 4 years |
| Guat Bee Goh | F | 47 |
Nanyang Technological University
| 4 years |
| Tiong Yuen Soh | M | 49 |
Nanyang Technological University
| 4 years |
| Sin Shen Kek | M | - |
Nanyang Technological University
| 4 years |
| Wee Kiat Chan | M | 49 |
Nanyang Technological University
| 4 years |
| Choon Kiat Boon | M | 49 |
Nanyang Technological University
| 4 years |
| Kay Seng Goh | M | 50 |
Nanyang Technological University
| 4 years |
| Kim Han Raymond Tan | M | 45 |
Nanyang Technological University
| 4 years |
| Chee Seng Chu | M | 50 |
Nanyang Technological University
| 4 years |
| Ou Chen | M | 40 |
Nanyang Technological University
| 4 years |
| Pin Jan Fong | M | 49 |
Nanyang Technological University
| 4 years |
| Khee Wee Hau | M | 48 |
Nanyang Technological University
| 4 years |
| Aik Khoon Chua | M | 51 |
Nanyang Technological University
| 4 years |
| See Ching Low | M | 49 |
Nanyang Technological University
| 4 years |
| Yi Ngo Low | M | 45 |
Nanyang Technological University
| 4 years |
| Tiong Gee Ng | M | 61 |
Nanyang Technological University
| 2 years |
| Poh Hean Kek | M | 47 |
Nanyang Technological University
| 4 years |
| Wei Shiu Kan | M | 48 |
Nanyang Technological University
| 4 years |
| Li Huang Lee | F | 47 |
Nanyang Technological University
| 4 years |
| Hu Xiang | M | 59 |
Nanyang Technological University
| 4 years |
| Jeremy Loh | M | 52 |
Nanyang Technological University
| 1 years |
| Chee Hoe Teh | M | 48 |
Nanyang Technological University
| 4 years |
| Kum Meng Yet | M | 53 |
Nanyang Technological University
| 2 years |
| Tak Sin Teo | M | 45 |
Nanyang Technological University
| 4 years |
| Wen Yuan Chiang | M | 50 |
Nanyang Technological University
| 4 years |
| Christopher Tay | M | - |
Nanyang Technological University
| 4 years |
| Lawrence Jiemin Wu | M | - |
Nanyang Technological University
| 3 years |
| Sean Seah | M | - |
Nanyang Technological University
| 4 years |
| Sen Wang | M | 50 |
Nanyang Technological University
| 3 years |
| Serene Tan | F | 46 |
Nanyang Technological University
| 4 years |
| He Wei Shi | M | 47 |
Nanyang Technological University
| 4 years |
| Alexander Ott | M | - |
Nanyang Technological University
| 2 years |
| Lay Fen Neo | F | 42 |
Nanyang Technological University
| 4 years |
| Ya Hui Xia | F | - |
Nanyang Technological University
| 4 years |
| Yuen Ting Kow | F | 46 |
Nanyang Technological University
| 4 years |
| Li Zhen Ong | F | 40 |
Nanyang Technological University
| 4 years |
| Seng Hee Teoh | M | 43 |
Nanyang Technological University
| 4 years |
| Yii Fan Lim | M | 48 |
Nanyang Technological University
| 4 years |
| Shi Kang Pang | M | 44 |
Nanyang Technological University
| 4 years |
| Ding Ding He | M | 47 |
Nanyang Technological University
| 4 years |
| Aaron Chan | M | - |
Nanyang Technological University
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Singapore | 87 | 87.00% |
| China | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jie Wen Gao
- Personal Network
